Treatment of BALB/c mice with purified pig anti-(BALB/c anti-nuclease) anti-idiotypic antibodies has been found to induce the appearance of idiotype-bearing immunoglobulins (Id') in the serum of these mice in the absence of detectable antigen binding activity. This phenomenon appeared to require T cells in the hosts because no Id' was detected in the serum of nude mice similarly treated. Furthermore, the spleens of BALB/c mice treated with anti-idiotype were found to contain helper T cells capable of providing help in an in vitro plaque-forming cell response to trinitrophenyl-nuclease equivalent to that provided by helper T cells from the spleens of nuclease-primed animals. Helper T cells from both anti-idiotype-treated and nuclease-treated animals were found to be antigen-specific and to be similarly susceptible to elimination by treatment with anti-idiotype plus complement. Therefore, treatment with both antigen and anti-idiotype appeared to prime similar populations of antigen-specific helper T cells, while having different effects on the induction of antibody. These findings are consistent with the network theory of receptor interactions in the immune response, and may provide a means for studying individual cell populations involved in such interactions.
Skip Nav Destination
Article navigation
1 July 1981
Article|
July 01 1981
Induction of idiotype-bearing, nuclease-specific helper T cells by in vivo treatment with anti-idiotype.
G G Miller
P I Nadler
Y Asano
R J Hodes
D H Sachs
Online ISSN: 1540-9538
Print ISSN: 0022-1007
J Exp Med (1981) 154 (1): 24–34.
Citation
G G Miller, P I Nadler, Y Asano, R J Hodes, D H Sachs; Induction of idiotype-bearing, nuclease-specific helper T cells by in vivo treatment with anti-idiotype.. J Exp Med 1 July 1981; 154 (1): 24–34. doi: https://doi.org/10.1084/jem.154.1.24
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement